Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab

Flora Elwes, Shyamanga Borooah*, Peter Aspinall, Peng Yong Sim, Cheng Yi Loo, Ana-Maria Armbrecht, Baljean Dhillon, Peter Cackett

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
23 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Psychology

Agricultural and Biological Sciences

Social Sciences